Search research articles
Contact Us
Filters
Showing results (211-220 of 269) with videos related to
Page
of 27
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 29, 2021
Steroid-Free Deep Remission at One Year Does Not Prevent Crohn's Disease Progression: Long-Term Data From the TAILORIX Trial
David Laharie, Geert D'Haens, Maria Nachury, et al.
Journal of Crohn'S & Colitis
|
January 13, 2025
Risankizumab efficacy and safety based on prior inadequate response or intolerance to advanced therapy: post hoc analysis of the INSPIRE and COMMAND phase 3 studies
Remo Panaccione, Edouard Louis, Jean-Frederic Colombel, et al.
The American Journal of Gastroenterology
|
December 6, 2012
Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion process
Laurent Peyrin-Biroulet, Vincent Billioud, Geert D'Haens, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 6, 2023
Reliability and Responsiveness of Histologic Indices for the Assessment of Crohn's Disease Activity
Virginia Solitano, David F Schaeffer, Malcolm Hogan, et al.
The New England Journal of Medicine
|
May 24, 2023
Upadacitinib Induction and Maintenance Therapy for Crohn's Disease
Edward V Loftus, Julian Panés, Ana P Lacerda, et al.
Gut
|
February 15, 2013
Oestrogens promote tumorigenesis in a mouse model for colitis-associated cancer
Jarom Heijmans, Mattheus C B Wielenga, Sanne Liesbeth Rosekrans, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 5, 2025
Extended Risankizumab Treatment in Patients With Crohn's Disease Who Did Not Achieve Clinical Response to Induction Treatment
Remo Panaccione, Marc Ferrante, Iris Dotan, et al.
The British Journal of Radiology
|
May 28, 2025
Quantified motility in Crohn's disease to evaluate stricture composition using cine-MRI
Kim J Beek, Kyra L van Rijn, Catherina S de Jonge, et al.
The Lancet. Gastroenterology & Hepatology
|
December 5, 2024
Efficacy and safety of filgotinib as induction and maintenance therapy for Crohn's disease (DIVERSITY): a phase 3, double-blind, randomised, placebo-controlled trial
Séverine Vermeire, Stefan Schreiber, David T Rubin, et al.
The Lancet. Gastroenterology & Hepatology
|
March 24, 2018
Chromoendoscopy versus autofluorescence imaging for neoplasia detection in patients with longstanding ulcerative colitis (FIND-UC): an international, multicentre, randomised controlled trial
Jasper L A Vleugels, Matt D Rutter, Krish Ragunath, et al.
Page
of 27
Search research articles
Search
Showing results (211-220 of 269) with videos related to
Sort By:
Page
of 27
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 29, 2021
Steroid-Free Deep Remission at One Year Does Not Prevent Crohn's Disease Progression: Long-Term Data From the TAILORIX Trial
David Laharie, Geert D'Haens, Maria Nachury, et al.
Journal of Crohn'S & Colitis
|
January 13, 2025
Risankizumab efficacy and safety based on prior inadequate response or intolerance to advanced therapy: post hoc analysis of the INSPIRE and COMMAND phase 3 studies
Remo Panaccione, Edouard Louis, Jean-Frederic Colombel, et al.
The American Journal of Gastroenterology
|
December 6, 2012
Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion process
Laurent Peyrin-Biroulet, Vincent Billioud, Geert D'Haens, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 6, 2023
Reliability and Responsiveness of Histologic Indices for the Assessment of Crohn's Disease Activity
Virginia Solitano, David F Schaeffer, Malcolm Hogan, et al.
The New England Journal of Medicine
|
May 24, 2023
Upadacitinib Induction and Maintenance Therapy for Crohn's Disease
Edward V Loftus, Julian Panés, Ana P Lacerda, et al.
Gut
|
February 15, 2013
Oestrogens promote tumorigenesis in a mouse model for colitis-associated cancer
Jarom Heijmans, Mattheus C B Wielenga, Sanne Liesbeth Rosekrans, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 5, 2025
Extended Risankizumab Treatment in Patients With Crohn's Disease Who Did Not Achieve Clinical Response to Induction Treatment
Remo Panaccione, Marc Ferrante, Iris Dotan, et al.
The British Journal of Radiology
|
May 28, 2025
Quantified motility in Crohn's disease to evaluate stricture composition using cine-MRI
Kim J Beek, Kyra L van Rijn, Catherina S de Jonge, et al.
The Lancet. Gastroenterology & Hepatology
|
December 5, 2024
Efficacy and safety of filgotinib as induction and maintenance therapy for Crohn's disease (DIVERSITY): a phase 3, double-blind, randomised, placebo-controlled trial
Séverine Vermeire, Stefan Schreiber, David T Rubin, et al.
The Lancet. Gastroenterology & Hepatology
|
March 24, 2018
Chromoendoscopy versus autofluorescence imaging for neoplasia detection in patients with longstanding ulcerative colitis (FIND-UC): an international, multicentre, randomised controlled trial
Jasper L A Vleugels, Matt D Rutter, Krish Ragunath, et al.
Page
of 27